Literature DB >> 20699441

Detection of EBV genomes in plasmablasts/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH.

Sara Calattini1, Irini Sereti, Philip Scheinberg, Hiroshi Kimura, Richard W Childs, Jeffrey I Cohen.   

Abstract

Epstein-Barr virus (EBV) is present in B cells in the blood of healthy people; few studies have looked for EBV in other cell types in blood from patients with lymphoproliferative disorders. We use a new technique combining immunofluorescent cell-surface staining and fluorescent in situ hybridization to quantify both EBV copy number per cell and cell types in blood from patients with high EBV DNA loads. In addition to CD20(+) B cells, EBV was present in plasmablast/plasma cells in the blood of 50% of patients, in monocytes or T cells in a small proportion of patients, and in "non-B, non-T, non-monocytes" in 69% of patients. The mean EBV copy number in B cells was significantly higher than in plasmablast/plasma cells. There was no correlation between EBV load and virus copy number per cell. Although we detected CD21, the EBV B-cell receptor, on EBV-infected B cells, we could not detect it on virus-infected T cells. These findings expand the range of cell types infected in the blood. Determining the number of EBV genomes per cell and the type of cells infected in patients with high EBV loads may provide additional prognostic information for the development of EBV lymphoproliferative diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20699441      PMCID: PMC2996115          DOI: 10.1182/blood-2010-05-285452

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  44 in total

1.  Infection of primary human monocytes by Epstein-Barr virus.

Authors:  M Savard; C Bélanger; M Tardif; P Gourde; L Flamand; J Gosselin
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 2.  Epstein-Barr virus: evasive maneuvers in the development of PTLD.

Authors:  Andrew L Snow; Olivia M Martinez
Journal:  Am J Transplant       Date:  2007-01-04       Impact factor: 8.086

3.  Increased Ig-null B lymphocytes in the peripheral blood of pediatric solid organ transplant recipients with elevated Epstein-Barr viral loads.

Authors:  Elizabeth Schauer; Steven Webber; Laurence Kingsley; Michael Green; David Rowe
Journal:  Pediatr Transplant       Date:  2008-06-28

4.  Epstein-Barr virus infection of Langerhans cell precursors as a mechanism of oral epithelial entry, persistence, and reactivation.

Authors:  Dennis M Walling; Autumn J Ray; Joan E Nichols; Catherine M Flaitz; C Mark Nichols
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

5.  Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.

Authors:  L Quintanilla-Martinez; S Kumar; F Fend; E Reyes; J Teruya-Feldstein; D W Kingma; L Sorbara; M Raffeld; S E Straus; E S Jaffe
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

6.  Surface immunoglobulin-deficient Epstein-Barr virus-infected B cells in the peripheral blood of pediatric solid-organ transplant recipients.

Authors:  Elizabeth Schauer; Steven Webber; Michael Green; David Rowe
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

7.  Blood-borne human plasma cells in steady state are derived from mucosal immune responses.

Authors:  Henrik E Mei; Taketoshi Yoshida; Wondossen Sime; Falk Hiepe; Kathi Thiele; Rudolf A Manz; Andreas Radbruch; Thomas Dörner
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

8.  Extramedullary plasmacytoma-like posttransplantation lymphoproliferative disorders: clinical and pathologic features.

Authors:  Bill G Richendollar; Eric D Hsi; James R Cook
Journal:  Am J Clin Pathol       Date:  2009-10       Impact factor: 2.493

9.  Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases.

Authors:  Hiroshi Kimura; Kanae Miyake; Yohei Yamauchi; Kana Nishiyama; Seiko Iwata; Keiji Iwatsuki; Kensei Gotoh; Seiji Kojima; Yoshinori Ito; Yukihiro Nishiyama
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226

10.  Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals.

Authors:  Susan Moir; Jason Ho; Angela Malaspina; Wei Wang; Angela C DiPoto; Marie A O'Shea; Gregg Roby; Shyam Kottilil; James Arthos; Michael A Proschan; Tae-Wook Chun; Anthony S Fauci
Journal:  J Exp Med       Date:  2008-07-14       Impact factor: 14.307

View more
  20 in total

1.  Epstein-Barr virus positive anaplastic large cell lymphoma: myth or reality?

Authors:  Ly Ma; Youval Katz; Kanu P Sharan; Roland Schwarting; Annette S Kim
Journal:  Int J Clin Exp Pathol       Date:  2010-11-20

2.  High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.

Authors:  Eric R Weiss; Galit Alter; Javier Gordon Ogembo; Jennifer L Henderson; Barbara Tabak; Yasin Bakiş; Mohan Somasundaran; Manuel Garber; Liisa Selin; Katherine Luzuriaga
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

3.  Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor.

Authors:  Javier G Ogembo; Lakshmi Kannan; Ionita Ghiran; Anne Nicholson-Weller; Robert W Finberg; George C Tsokos; Joyce D Fingeroth
Journal:  Cell Rep       Date:  2013-02-14       Impact factor: 9.423

4.  CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia.

Authors:  Joris M van Montfrans; Andy I M Hoepelman; Sigrid Otto; Marielle van Gijn; Lisette van de Corput; Roel A de Weger; Linda Monaco-Shawver; Pinaki P Banerjee; Elisabeth A M Sanders; Cornelia M Jol-van der Zijde; Michael R Betts; Jordan S Orange; Andries C Bloem; Kiki Tesselaar
Journal:  J Allergy Clin Immunol       Date:  2011-12-24       Impact factor: 10.793

5.  Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.

Authors:  Jeffrey I Cohen; Elaine S Jaffe; Janet K Dale; Stefania Pittaluga; Helen E Heslop; Cliona M Rooney; Stephen Gottschalk; Catherine M Bollard; V Koneti Rao; Adriana Marques; Peter D Burbelo; Siu-Ping Turk; Rachael Fulton; Alan S Wayne; Richard F Little; Mitchell S Cairo; Nader K El-Mallawany; Daniel Fowler; Claude Sportes; Michael R Bishop; Wyndham Wilson; Stephen E Straus
Journal:  Blood       Date:  2011-03-31       Impact factor: 22.113

6.  Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines.

Authors:  Carrie B Coleman; Eric M Wohlford; Nicholas A Smith; Christine A King; Julie A Ritchie; Paul C Baresel; Hiroshi Kimura; Rosemary Rochford
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

7.  The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases.

Authors:  Jennifer A Kanakry; Aparna M Hegde; Christine M Durand; Allan B Massie; Amy E Greer; Richard F Ambinder; Alexandra Valsamakis
Journal:  Blood       Date:  2016-01-07       Impact factor: 22.113

8.  Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D.

Authors:  Benjamin Chaigne-Delalande; Feng-Yen Li; Geraldine M O'Connor; Marshall J Lukacs; Ping Jiang; Lixin Zheng; Amber Shatzer; Matthew Biancalana; Stefania Pittaluga; Helen F Matthews; Timothy J Jancel; Jack J Bleesing; Rebecca A Marsh; Taco W Kuijpers; Kim E Nichols; Carrie L Lucas; Sunil Nagpal; Huseyin Mehmet; Helen C Su; Jeffrey I Cohen; Gulbu Uzel; Michael J Lenardo
Journal:  Science       Date:  2013-07-12       Impact factor: 47.728

9.  How I treat T-cell chronic active Epstein-Barr virus disease.

Authors:  Catherine M Bollard; Jeffrey I Cohen
Journal:  Blood       Date:  2018-04-30       Impact factor: 22.113

10.  Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event.

Authors:  David M Burns; Rose Tierney; Claire Shannon-Lowe; Jo Croudace; Charlotte Inman; Ben Abbotts; Sandeep Nagra; Christopher P Fox; Sridhar Chaganti; Charles F Craddock; Paul Moss; Alan B Rickinson; Martin Rowe; Andrew I Bell
Journal:  Blood       Date:  2015-10-08       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.